Delivery Order SPE2DB20D1100-SPE2DB25FE1MN
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Atovaquone-Proguanil 250-100 tablets (100-count packages) valued at $1,252.50. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The contract specifies September 29, 2025, as the ultimate completion date, with performance to be fulfilled at AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $22,254 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Atovaquone-Proguanil 250-100 100 tablets. This delivery order represents a firm fixed-price contract with an ultimate completion date of September 29, 2025, and was awarded on a competitive basis with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Atovaquone-Proguanil 250-100 in a quantity of 100 units, with a ceiling value of $4,882.70. This award utilized firm fixed price pricing and is classified as a non-set-aside competitive procurement. The delivery order is contingent upon completion by August 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100mg tablets (100-count) valued at $11,793.54. The contract employs firm fixed pricing with a completion date of September 26, 2025, and was competitively awarded without set-aside restrictions. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,343.16 on September 9, 2025, for Atovaquone-Proguanil 250-100 (100 tablets), with a completion date of September 10, 2025. This is a firm fixed-price delivery order under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical supply needs. The order...
- AmerisourceBergen Drug Corp was awarded a delivery order for Atovaquone-Proguanil 250-100 mg unit dose packages (24-count) valued at $3,382.01 by the Defense Logistics Agency's Medical Supply Chain on September 15, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation and a performance location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is expected to be completed by September 16,...
- The Defense Logistics Agency awarded a $2,248.56 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 tablets (100-count supply). The contract, which is firm fixed price with no set-aside designation, was awarded on August 18, 2025, and is scheduled for completion by August 19, 2025. Performance will be executed at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,343.16 to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Atovaquone-Proguanil 250-100mg in quantities of 100 tablets. The contract, which is firm fixed price with an ultimate completion date of April 24, 2025, carries no set-aside designation and was competitively awarded. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $7,718.44 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Atovaquone-Proguanil 250-100mg in quantities of 100 tablets. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The work will be...
- The Defense Logistics Agency awarded a $44,740.80 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 tablets (100 count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded contract utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performs the work at its corporate office location. The delivery order falls under...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1MNDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Atovaquone-Proguanil 250-100 in quantities of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of approximately $30.9K and is scheduled for completion by September 30, 2025. The contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's broader pharmaceutical supply agreement with the DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order falls under the company's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9M through December 2026, which functions as a global pharmaceutical support vehicle enabling the supply of medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.9k | 9/29/25 |